Facebook
Linkedin
Twitter
Home
News
Business
Technology
Property
Human Capital Reviews
Circular Economy
Event Calendar
Reports
Opinions
Arts
Arts & Design
Culture & Entertainment
Living
Travel
Food
Health & Wellness
Sport
Newswires
Business Wire
PRNewswire
Media OutReach
GlobeNewswire
Search
News Hub Asia
24.7
C
Kuala Lumpur
Friday, December 5, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
News
Business
Technology
Property
Human Capital Reviews
Circular Economy
Event Calendar
Reports
Opinions
Arts
Arts & Design
Culture & Entertainment
Living
Travel
Food
Health & Wellness
Sport
Newswires
Business Wire
PRNewswire
Media OutReach
GlobeNewswire
Home
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101
135873_GettyImages-484324248
135873_GettyImages-484324248
